| Year |
Citation |
Score |
| 2023 |
Scur M, Parsons BD, Dey S, Makrigiannis AP. The diverse roles of C-type lectin-like receptors in immunity. Frontiers in Immunology. 14: 1126043. PMID 36923398 DOI: 10.3389/fimmu.2023.1126043 |
0.355 |
|
| 2023 |
Al Olabi R, Hendy AEA, Alkassab MB, Alnajm K, Elias M, Ibrahim M, Carlyle JR, Makrigiannis AP, Rahim MMA. The inhibitory NKR-P1B receptor regulates NK cell-mediated mammary tumor immunosurveillance in mice. Oncoimmunology. 12: 2168233. PMID 36704449 DOI: 10.1080/2162402X.2023.2168233 |
0.462 |
|
| 2020 |
Wight A, Parsons BD, Rahim MMA, Makrigiannis AP. A Central Role for Ly49 Receptors in NK Cell Memory. Journal of Immunology (Baltimore, Md. : 1950). 204: 2867-2875. PMID 32423924 DOI: 10.4049/Jimmunol.2000196 |
0.423 |
|
| 2020 |
Rahim MMA, Parsons BD, Price EL, Slaine PD, Chilvers BL, Seaton GS, Wight A, Medina-Luna D, Dey S, Grandy SL, Anderson LE, Zamorano Cuervo N, Grandvaux N, Gaglia MM, Kelvin AA, ... ... Makrigiannis AP, et al. Defective influenza A virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins. Journal of Virology. PMID 32321802 DOI: 10.1128/Jvi.00165-20 |
0.39 |
|
| 2019 |
Aguilar OA, Sampaio IS, Rahim MMA, Samaniego JD, Tilahun ME, Krishnamoorthy M, Popović B, Babić M, Krmpotić A, Treanor B, Margulies DH, Allan DSJ, Makrigiannis AP, Jonjić S, Carlyle JR. Mouse cytomegalovirus m153 protein stabilizes expression of the inhibitory NKR-P1B ligand, Clr-b. Journal of Virology. PMID 31597762 DOI: 10.1128/Jvi.01220-19 |
0.498 |
|
| 2018 |
Abou-Samra E, Hickey Z, Aguilar OA, Scur M, Mahmoud AB, Pyatibrat S, Tu MM, Francispillai J, Mortha A, Carlyle JR, Rahim MMA, Makrigiannis AP. NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections. Cellular & Molecular Immunology. PMID 30275537 DOI: 10.1038/S41423-018-0169-X |
0.53 |
|
| 2018 |
Wight A, Mahmoud AB, Scur M, Tu MM, Rahim MMA, Sad S, Makrigiannis AP. Critical role for the Ly49 family of class I MHC receptors in adaptive natural killer cell responses. Proceedings of the National Academy of Sciences of the United States of America. PMID 30249666 DOI: 10.1073/Pnas.1722374115 |
0.488 |
|
| 2018 |
Margraf A, Volmering S, Skupski J, Van Marck V, Makrigiannis AP, Block H, Zarbock A. The ITIM Domain-Containing NK Receptor Ly49Q Impacts Pulmonary Infection by Mediating Neutrophil Functions. Journal of Immunology (Baltimore, Md. : 1950). PMID 29712775 DOI: 10.4049/Jimmunol.1701084 |
0.339 |
|
| 2017 |
Tu MM, Rahim MMA, Sayed C, Mahmoud AB, Makrigiannis AP. Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC Receptors. Cancer Immunology Research. PMID 28924054 DOI: 10.1158/2326-6066.Cir-17-0056 |
0.471 |
|
| 2017 |
Aguilar OA, Berry R, Rahim MM, Reichel JJ, Popović B, Tanaka M, Fu Z, Balaji GR, Lau TN, Tu MM, Kirkham CL, Mahmoud AB, Mesci A, Krmpotić A, Allan DS, ... Makrigiannis AP, et al. A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family. Cell. 169: 58-71.e14. PMID 28340350 DOI: 10.1016/J.Cell.2017.03.002 |
0.481 |
|
| 2017 |
Alkayyal AA, Tai LH, Kennedy MA, Tanese de Souza C, Zhang J, Lefebvre C, Sahi S, Ananth AA, Mahmoud AB, Makrigiannis AP, Cron GO, Macdonald B, Marginean EC, Stojdl DF, Bell JC, et al. NK-cell Recruitment Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine. Cancer Immunology Research. PMID 28159747 DOI: 10.1158/2326-6066.Cir-16-0162 |
0.412 |
|
| 2016 |
Mahmoud AB, Tu MM, Wight A, Zein HS, Rahim MM, Lee SH, Sekhon HS, Brown EG, Makrigiannis AP. Correction: Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion. Plos Pathogens. 12: e1006021. PMID 27814389 DOI: 10.1371/Journal.Ppat.1006021 |
0.35 |
|
| 2016 |
Rahim MM, Wight A, Mahmoud AB, Aguilar OA, Lee SH, Vidal SM, Carlyle JR, Makrigiannis AP. Expansion and Protection by a Virus-Specific NK Cell Subset Lacking Expression of the Inhibitory NKR-P1B Receptor during Murine Cytomegalovirus Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 27511735 DOI: 10.4049/Jimmunol.1600776 |
0.548 |
|
| 2016 |
Tu MM, Mahmoud AB, Makrigiannis AP. Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control. Frontiers in Immunology. 7: 166. PMID 27199990 DOI: 10.3389/Fimmu.2016.00166 |
0.567 |
|
| 2016 |
Wight A, Yang D, Ioshikhes I, Makrigiannis AP. Nucleosome Presence at AML-1 Binding Sites Inversely Correlates with Ly49 Expression: Revelations from an Informatics Analysis of Nucleosomes and Immune Cell Transcription Factors. Plos Computational Biology. 12: e1004894. PMID 27124577 DOI: 10.1371/Journal.Pcbi.1004894 |
0.328 |
|
| 2016 |
Leon L, Felker AM, Kay VR, Tu MM, Makrigiannis AP, Croy BA. Ly49 knockdown in mice results in aberrant uterine crypt formation and impaired blastocyst implantation. Placenta. 39: 147-50. PMID 26992687 DOI: 10.1016/J.Placenta.2016.01.013 |
0.446 |
|
| 2016 |
Mahmoud AB, Tu MM, Wight A, Zein HS, Rahim MM, Lee SH, Sekhon HS, Brown EG, Makrigiannis AP. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion. Plos Pathogens. 12: e1005446. PMID 26928844 DOI: 10.1371/Journal.Ppat.1005446 |
0.565 |
|
| 2015 |
Rahim MM, Makrigiannis AP. Ly49 receptors: evolution, genetic diversity, and impact on immunity. Immunological Reviews. 267: 137-47. PMID 26284475 DOI: 10.1111/Imr.12318 |
0.564 |
|
| 2015 |
Chen P, Aguilar OA, Rahim MM, Allan DS, Fine JH, Kirkham CL, Ma J, Tanaka M, Tu MM, Wight A, Kartsogiannis V, Gillespie MT, Makrigiannis AP, Carlyle JR. Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model. Journal of Immunology (Baltimore, Md. : 1950). 194: 2909-18. PMID 25681346 DOI: 10.4049/Jimmunol.1401523 |
0.503 |
|
| 2015 |
Rahim MM, Chen P, Mottashed AN, Mahmoud AB, Thomas MJ, Zhu Q, Brooks CG, Kartsogiannis V, Gillespie MT, Carlyle JR, Makrigiannis AP. The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses. Blood. 125: 2217-27. PMID 25612621 DOI: 10.1182/Blood-2014-02-556142 |
0.545 |
|
| 2014 |
Wei H, Nash WT, Makrigiannis AP, Brown MG. Impaired NK-cell education diminishes resistance to murine CMV infection. European Journal of Immunology. 44: 3273-82. PMID 25187217 DOI: 10.1002/Eji.201444800 |
0.498 |
|
| 2014 |
Lima PD, Tu MM, Rahim MM, Peng AR, Croy BA, Makrigiannis AP. Ly49 receptors activate angiogenic mouse DBA⁺ uterine natural killer cells. Cellular & Molecular Immunology. 11: 467-76. PMID 24954223 DOI: 10.1038/Cmi.2014.44 |
0.428 |
|
| 2014 |
Tu MM, Mahmoud AB, Wight A, Mottashed A, Bélanger S, Rahim MM, Abou-Samra E, Makrigiannis AP. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells. Cancer Research. 74: 3684-94. PMID 24802191 DOI: 10.1158/0008-5472.Can-13-3021 |
0.581 |
|
| 2014 |
Klingel K, Fabritius C, Sauter M, Göldner K, Stauch D, Kandolf R, Ettischer N, Gahlen S, Schönberger T, Ebner S, Makrigiannis AP, Bélanger S, Diefenbach A, Polić B, Pratschke J, et al. The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy. The Journal of Pathology. 234: 164-77. PMID 24797160 DOI: 10.1002/Path.4369 |
0.706 |
|
| 2014 |
Rahim MM, Tu MM, Mahmoud AB, Wight A, Abou-Samra E, Lima PD, Makrigiannis AP. Ly49 receptors: innate and adaptive immune paradigms. Frontiers in Immunology. 5: 145. PMID 24765094 DOI: 10.3389/Fimmu.2014.00145 |
0.574 |
|
| 2014 |
Zhang J, Tai LH, Ilkow CS, Alkayyal AA, Ananth AA, de Souza CT, Wang J, Sahi S, Ly L, Lefebvre C, Falls TJ, Stephenson KB, Mahmoud AB, Makrigiannis AP, Lichty BD, et al. Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1320-32. PMID 24695102 DOI: 10.1038/Mt.2014.60 |
0.413 |
|
| 2013 |
McFall E, Tu MM, Al-Khattabi N, Tai LH, St-Laurent AS, Tzankova V, Hall CW, Belanger S, Troke AD, Wight A, Mahmoud AB, Zein HS, Rahim MM, Carlyle JR, Makrigiannis AP. Optimized tetramer analysis reveals Ly49 promiscuity for MHC ligands. Journal of Immunology (Baltimore, Md. : 1950). 191: 5722-9. PMID 24154624 DOI: 10.4049/Jimmunol.1300726 |
0.675 |
|
| 2013 |
Tai LH, Zhang J, Scott KJ, de Souza CT, Alkayyal AA, Ananth AA, Sahi S, Adair RA, Mahmoud AB, Sad S, Bell JC, Makrigiannis AP, Melcher AA, Auer RC. Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5104-15. PMID 23881927 DOI: 10.1158/1078-0432.Ccr-13-0246 |
0.336 |
|
| 2013 |
Rahim MM, Tai LH, Troke AD, Mahmoud AB, Abou-Samra E, Roy JG, Mottashed A, Ault N, Corbeil C, Goulet ML, Zein HS, Hamilton-Valensky M, Krystal G, Kerr WG, Toyama-Sorimachi N, ... Makrigiannis AP, et al. Ly49Q positively regulates type I IFN production by plasmacytoid dendritic cells in an immunoreceptor tyrosine-based inhibitory motif-dependent manner. Journal of Immunology (Baltimore, Md. : 1950). 190: 3994-4004. PMID 23479228 DOI: 10.4049/Jimmunol.1200873 |
0.49 |
|
| 2013 |
Tai LH, De Souza CT, Bélanger S, Ly L, Alkayyal AA, Zhang J, Rintoul JL, Ananth AA, Lam T, Breitbach CJ, Falls TJ, Kirn DH, Bell JC, Makrigiannis AP, Auer RA. Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells Cancer Research. 73: 97-107. PMID 23090117 DOI: 10.1158/0008-5472.Can-12-1993 |
0.668 |
|
| 2013 |
Tai L, Souza C, Makrigiannis A, Auer R. Ex vivo Natural Killer Cell Cytotoxicity Assay Bio-Protocol. 3. DOI: 10.21769/BIOPROTOC.863 |
0.319 |
|
| 2013 |
Bélanger S, Tu MM, Rahim MMA, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice (Blood (2012) 120, 3(592-602)) Blood. 122: 2525. DOI: 10.1182/Blood-2013-08-524249 |
0.58 |
|
| 2013 |
Lima P, Rahim MM, Tu M, Peng A, Anne Croy B, Makrigiannis A. KIR-like LY49 Receptors: Insights into pregnancy complications linked to inhibition of uterine Natural Killer cell functions Placenta. 34: A58. DOI: 10.1016/J.Placenta.2013.06.174 |
0.393 |
|
| 2012 |
Zhang Q, Rahim MM, Allan DS, Tu MM, Belanger S, Abou-Samra E, Ma J, Sekhon HS, Fairhead T, Zein HS, Carlyle JR, Anderson SK, Makrigiannis AP. Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance. Plos One. 7: e50561. PMID 23226525 DOI: 10.1371/Journal.Pone.0050561 |
0.626 |
|
| 2012 |
Bélanger S, Tu MM, Rahim MM, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood. 120: 592-602. PMID 22661698 DOI: 10.1182/Blood-2012-02-408732 |
0.715 |
|
| 2012 |
Heyward CY, Patel R, Mace EM, Grier JT, Guan H, Makrigiannis AP, Orange JS, Ricciardi RP. Tumorigenic adenovirus 12 cells evade NK cell lysis by reducing the expression of NKG2D ligands. Immunology Letters. 144: 16-23. PMID 22445355 DOI: 10.1016/J.Imlet.2012.03.001 |
0.493 |
|
| 2011 |
Chen P, Bélanger S, Aguilar OA, Zhang Q, St-Laurent A, Rahim MM, Makrigiannis AP, Carlyle JR. Analysis of the mouse 129-strain Nkrp1-Clr gene cluster reveals conservation of genomic organization and functional receptor-ligand interactions despite significant allelic polymorphism. Immunogenetics. 63: 627-40. PMID 21667046 DOI: 10.1007/S00251-011-0542-8 |
0.644 |
|
| 2010 |
Patel R, Bélanger S, Tai LH, Troke AD, Makrigiannis AP. Effect of Ly49 haplotype variance on NK cell function and education. Journal of Immunology (Baltimore, Md. : 1950). 185: 4783-92. PMID 20855875 DOI: 10.4049/Jimmunol.1001287 |
0.729 |
|
| 2010 |
Xie X, Stadnisky MD, Coats ER, Ahmed Rahim MM, Lundgren A, Xu W, Makrigiannis AP, Brown MG. MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus. Proceedings of the National Academy of Sciences of the United States of America. 107: 8754-9. PMID 20421478 DOI: 10.1073/Pnas.0913126107 |
0.451 |
|
| 2010 |
Hayashi M, Nakashima T, Kodama T, Makrigiannis AP, Toyama-Sorimachi N, Takayanagi H. Ly49Q, an ITIM-bearing NK receptor, positively regulates osteoclast differentiation. Biochemical and Biophysical Research Communications. 393: 432-8. PMID 20153723 DOI: 10.1016/J.Bbrc.2010.02.013 |
0.446 |
|
| 2009 |
Yoshizaki M, Tazawa A, Kasumi E, Sasawatari S, Itoh K, Dohi T, Sasazuki T, Inaba K, Makrigiannis AP, Toyama-Sorimachi N. Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q. Blood. 114: 1518-27. PMID 19528537 DOI: 10.1182/Blood-2008-12-192344 |
0.421 |
|
| 2008 |
Tai LH, Goulet ML, Belanger S, Toyama-Sorimachi N, Fodil-Cornu N, Vidal SM, Troke AD, McVicar DW, Makrigiannis AP. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. The Journal of Experimental Medicine. 205: 3187-99. PMID 19075287 DOI: 10.1084/Jem.20080718 |
0.661 |
|
| 2008 |
Fodil-Cornu N, Lee SH, Belanger S, Makrigiannis AP, Biron CA, Buller RM, Vidal SM. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. Journal of Immunology (Baltimore, Md. : 1950). 181: 6394-405. PMID 18941230 DOI: 10.4049/Jimmunol.181.9.6394 |
0.673 |
|
| 2008 |
Makrigiannis AP, Parham P. The evolution of NK cell diversity. Seminars in Immunology. 20: 309-10. PMID 18938087 DOI: 10.1016/J.Smim.2008.09.004 |
0.476 |
|
| 2008 |
Belanger S, Tai LH, Anderson SK, Makrigiannis AP. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes and Immunity. 9: 509-21. PMID 18528402 DOI: 10.1038/Gene.2008.43 |
0.65 |
|
| 2007 |
Tai LH, Goulet ML, Belanger S, Troke AD, St-Laurent AG, Mesci A, Toyama-Sorimachi N, Carlyle JR, Makrigiannis AP. Recognition of H-2K(b) by Ly49Q suggests a role for class Ia MHC regulation of plasmacytoid dendritic cell function. Molecular Immunology. 44: 2638-46. PMID 17240452 DOI: 10.1016/J.Molimm.2006.12.010 |
0.638 |
|
| 2006 |
Mesci A, Ljutic B, Makrigiannis AP, Carlyle JR. NKR-P1 biology: from prototype to missing self. Immunologic Research. 35: 13-26. PMID 17003506 DOI: 10.1385/IR:35:1:13 |
0.436 |
|
| 2006 |
Carlyle JR, Mesci A, Ljutic B, Belanger S, Tai LH, Rousselle E, Troke AD, Proteau MF, Makrigiannis AP. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. Journal of Immunology (Baltimore, Md. : 1950). 176: 7511-24. PMID 16751398 DOI: 10.4049/Jimmunol.176.12.7511 |
0.673 |
|
| 2006 |
Goulet M, Fodil N, Troke AD, Toyama-Sorimachi N, Rousselle E, Vidal SM, Makrigiannis AP. Su.44. Enhanced Proliferation and Hematopoiesis in Ly49q-Deficient Mice Clinical Immunology. 119: S174-S175. DOI: 10.1016/J.Clim.2006.04.471 |
0.343 |
|
| 2005 |
Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Genes and Immunity. 6: 481-92. PMID 15931229 DOI: 10.1038/sj.gene.6364232 |
0.432 |
|
| 2005 |
Desrosiers MP, Kielczewska A, Loredo-Osti JC, Adam SG, Makrigiannis AP, Lemieux S, Pham T, Lodoen MB, Morgan K, Lanier LL, Vidal SM. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nature Genetics. 37: 593-9. PMID 15895081 DOI: 10.1038/Ng1564 |
0.388 |
|
| 2005 |
Makrigiannis AP, Patel D, Goulet ML, Dewar K, Anderson SK. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes and Immunity. 6: 71-83. PMID 15674375 DOI: 10.1038/sj.gene.6364154 |
0.356 |
|
| 2004 |
Proteau MF, Rousselle E, Makrigiannis AP. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomics. 84: 669-77. PMID 15475244 DOI: 10.1016/J.Ygeno.2004.05.004 |
0.434 |
|
| 2004 |
Makrigiannis AP, Rousselle E, Anderson SK. Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. Journal of Immunology (Baltimore, Md. : 1950). 172: 1414-25. PMID 14734717 DOI: 10.4049/Jimmunol.172.3.1414 |
0.556 |
|
| 2003 |
Makrigiannis AP, Anderson SK. Regulation of natural killer cell function. Cancer Biology & Therapy. 2: 610-6. PMID 14688463 DOI: 10.4161/Cbt.2.6.560 |
0.572 |
|
| 2002 |
McVicar DW, Winkler-Pickett R, Taylor LS, Makrigiannis A, Bennett M, Anderson SK, Ortaldo JR. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. Journal of Immunology (Baltimore, Md. : 1950). 169: 1721-8. PMID 12165492 DOI: 10.4049/Jimmunol.169.4.1721 |
0.521 |
|
| 2002 |
Saleh A, Makrigiannis AP, Hodge DL, Anderson SK. Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. Journal of Immunology (Baltimore, Md. : 1950). 168: 5163-9. PMID 11994471 DOI: 10.4049/Jimmunol.168.10.5163 |
0.46 |
|
| 2002 |
Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics. 79: 437-44. PMID 11863373 DOI: 10.1006/Geno.2002.6724 |
0.397 |
|
| 2001 |
Makrigiannis AP, Pau AT, Saleh A, Winkler-Pickett R, Ortaldo JR, Anderson SK. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. Journal of Immunology (Baltimore, Md. : 1950). 166: 5034-43. PMID 11290784 DOI: 10.4049/Jimmunol.166.8.5034 |
0.538 |
|
| 2001 |
Makrigiannis AP, Anderson SK. The murine Ly49 family: Form and function Archivum Immunologiae Et Therapiae Experimentalis. 49: 47-50. |
0.373 |
|
| 2000 |
Makrigiannis AP, Etzler J, Winkler-Pickett R, Mason A, Ortaldo JR, Anderson SK. Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. Journal of Leukocyte Biology. 68: 765-71. PMID 11073118 DOI: 10.1189/Jlb.68.5.765 |
0.526 |
|
| 2000 |
Makrigiannis AP, Anderson SK. Ly49 gene expression in different inbred mouse strains. Immunologic Research. 21: 39-47. PMID 10803882 DOI: 10.1385/Ir:21:1:39 |
0.421 |
|
| 2000 |
Gosselin P, Makrigiannis AP, Nalewaik R, Anderson SK. Characterization of the Ly49I promoter. Immunogenetics. 51: 326-31. PMID 10803845 DOI: 10.1007/S002510050626 |
0.386 |
|
| 1999 |
Makrigiannis AP, Musgrave BL, Hoskin DW. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic t lymphocyte development in response to anti-CD3 antibody Journal of Leukocyte Biology. 66: 792-802. PMID 10577511 DOI: 10.1002/Jlb.66.5.792 |
0.395 |
|
| 1999 |
Makrigiannis AP, Gosselin P, Mason LH, Taylor LS, McVicar DW, Ortaldo JR, Anderson SK. Cloning and characterization of a novel activating Ly49 closely related to Ly49A. Journal of Immunology (Baltimore, Md. : 1950). 163: 4931-8. PMID 10528196 |
0.366 |
|
| 1999 |
Musgrave BL, Phu T, Butler JJ, Makrigiannis AP, Hoskin DW. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway. Experimental Cell Research. 252: 96-103. PMID 10502402 DOI: 10.1006/Excr.1999.4631 |
0.397 |
|
| 1998 |
Hoskin DW, Williams B, Fitzpatrick L, Makrigiannis AP. Cell biology and possible therapeutic applications of anti-CD3-activated killer-T cells (review) International Journal of Molecular Medicine. 1: 893-902. PMID 9852313 DOI: 10.3892/Ijmm.1.5.893 |
0.375 |
|
| 1998 |
Hoskin DW, Taylor RM, Makrigiannis AP, James H, Lee TD. Dose-dependent enhancing and inhibitory effects of A77 1726 (leflunomide) on cytotoxic T lymphocyte induction. International Journal of Immunopharmacology. 20: 505-13. PMID 9818794 DOI: 10.1016/S0192-0561(98)00051-4 |
0.312 |
|
| 1997 |
Greene AL, Makrigiannis AP, Fitzpatrick L, Hoskin DW. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules Journal of Interferon and Cytokine Research. 17: 727-737. PMID 9452360 DOI: 10.1089/Jir.1997.17.727 |
0.35 |
|
| 1997 |
Williams BA, Makrigiannis AP, Blay J, Hoskin DW. Treatment of the p815 murine mastocytoma with cisplatin or etoposide up- regulates cell-surface fas (CD95) expression and increases sensitivity to anti-fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells International Journal of Cancer. 73: 416-423. PMID 9359490 DOI: 10.1002/(Sici)1097-0215(19971104)73:3<416::Aid-Ijc17>3.0.Co;2-A |
0.4 |
|
| 1996 |
Hoskin DW, Phu T, Makrigiannis AP. Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody International Journal of Immunopharmacology. 18: 623-631. PMID 9089006 DOI: 10.1016/S0192-0561(96)00069-0 |
0.465 |
|
| 1996 |
Fitzpatrick L, Makrigiannis AP, Kaiser M, Hoskin DW. Anti-CD3-activated killer T cells: Interferon-γ and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity Journal of Interferon and Cytokine Research. 16: 537-546. PMID 8836920 DOI: 10.1089/Jir.1996.16.537 |
0.388 |
|
| Show low-probability matches. |